Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News MYND Life Sciences Inc MYNDF


Primary Symbol: C.MYND

Healthcare Biotechnology
MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada.

Current News (CSE:MYND)

CSE Bulletin: Suspension - MYND Life Sciences Inc. (MYND)

Newsfile May 1, 2025

Canadian Investment Regulatory Organization Trading Halt - MYND

Canada NewsWire May 1, 2025

Management Cease Trade Order Status Report

Newsfile April 9, 2025

Management Cease Trade Order Status Report

Newsfile March 24, 2025

Management Cease Trade Order Granted

Newsfile March 3, 2025

MYND Life Sciences Announces Shares for Debt Transaction

Newsfile February 11, 2025

MYND Life Sciences Announces the Issuance of 4,000,001 Shares at $0.71/share

Newsfile January 17, 2025

MYND Life Sciences Announces Successful Conclusion of Debenture Settlement Agreement and Leadership Transition

Newsfile January 10, 2025

MYND Life Sciences Announces Strategic Debt Reduction and New Board Member Appointment

Newsfile November 22, 2024
View More News ››

Opinion & Analysis (CSE:MYND)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:MYND)

News

Somethng may be brewing...
wealth100 - November 23, 2024

MYND Announces Update on Debenture Payment Obligations

 VANCOUVER, BRITISH COLUMBIA, September 11, 2023 – MYND Life Sciences Inc. (CSE:MYND)(OTC:MYNDF) (“MYND” or the “Company”) today...
AVandelay - September 11, 2023

RE:MYND Life Sciences Inc. Achieves a Major Milestone

Under the radar...maybe
wealth100 - April 7, 2023

MYND Life Sciences Inc. Achieves a Major Milestone

This seems like a major development, but not much reaction in the stock ... ------------------------ Identification of a potent...
AVandelay - March 15, 2023

MYND Life Sciences celebrates Dr. Wilf Jefferies milestone

MYND Life Sciences celebrates Dr. Wilf Jefferies induction as a National Academy of Inventors Fellow
BMcCutcheon - June 17, 2022

MYND announces innovation in psilocybin dosing

https://themarketherald.ca/mynd-life-sciences-announces-new-testing-methodologies-for-measuring-cellular-responses-to-microdosing-with...
TrevorAbes - June 1, 2022
View more Bullboard ››

Sranan Gold Corp.

Sranan Gold Corp.

Sranan Gold Corp. develops, acquires, and explores mineral properties in Canada. The company primarily explores gold deposits ...
View More »